About the Discussion

@NEJMres360 Journal Club: Hosted by University of Tennessee Health Science Center Internal Medicine Residency Program on Apixaban to Prevent Venous Thromboembolism in Patients with Cancer and Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer

We have invited the residents and faculty from the University of Tennessee Health Science Center Internal Medicine Residency Program to engage in a journal club discussion about the NEJM articles, "Apixaban to Prevent Venous Thromboembolism in Patients with Cancer," found here: http://www.nejm.org/doi/full/10.1056/NEJMoa1814468, and "Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer," found here: http://www.nejm.org/doi/full/10.1056/NEJMoa1814630. Come and be a part of the conversation with your own questions and comments!